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Abstract
Wheat flour cannot be tolerated by those who suffer allergies to gluten. Human pathologies associated with grain proteins
have increased worldwide in recent years, and the only effective treatment available is a lifelong gluten-free diet, which is
complicated to follow and detrimental to gut health. This manuscript describes the development of wheat bread potentially
suitable for celiac patients and other gluten-intolerant individuals. We have made bread using wheat flour with very low
content of the specific gluten proteins (near gliadin-free) that are the causal agents for pathologies such as celiac disease.
Loaves were compared with normal wheat breads and rice bread. Organoleptic, nutritional, and immunotoxic properties
were studied. The reduced-gliadin breads showed baking and sensory properties, and overall acceptance, similar to those of
normal flour, but with up to 97% lower gliadin content. Moreover, the low-gliadin flour has improved nutritional properties
since its lysine content is significantly higher than that of normal flour. Conservative estimates indicate that celiac patients
could safely consume 67 grams of bread per day that is made with low-gliadin flour. However, additional studies, such as
feeding trials with gluten-intolerant patients, are still needed in order to determine whether or not the product can be
consumed by the general celiac population, as well as the actual tolerated amount that can be safely ingested. The results
presented here offer a major opportunity to improve the quality of life for millions of sufferers of gluten intolerance
throughout the world.
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Introduction
Wheat is a major component of most worldwide diets because of
its nutritional quality, and the ability of its flour to produce a
variety of tasty and satisfying foods. This is a consequence of the
unique viscoelastic properties of wheat dough, which allow the
entrapment of CO2 during fermentation, enabling the preparation
of leavened breads and other baked products. These wheat
products make substantial contributions to the dietary intake of
energy and protein, and supply dietary fiber, minerals, vitamins,
and phytochemicals [1]. A number of countries recommend
consuming 250 g–350 g of bread per day (depending on national
food habits), and the World Health Organization (WHO)
recommends eating bread several times per day [2]. However,
wheat products can have negative impacts on human health for
those who experience allergies and intolerances. Three pathologies
are associated with gluten intake: a) food allergy to wheat, which
affects 0.2–0.5% of the population [3], b) celiac disease (CD), a
permanent intolerance to gluten not only from wheat, but also
related proteins from rye, barley and some oats, that affects both
children and adults at various frequencies [4–7], and c) gluten
sensitivity, a new pathology in which gluten ingestion leads to
morphological or symptomatic manifestations despite the absence
of CD or wheat allergy [8], with an estimated prevalence of 6% in
the USA population. The incidence of these pathologies have
increased in recent years both in Europe and the USA, although it
is unclear whether this increase can be attributed to the better
detection rate, agronomic practices, the use of gluten as a food
additive, or breeding for higher protein content [9,10].
CD is the most studied of the three pathologies and is the result
of a complex interaction between genetic and environmental
factors. The former is determined by the presence of class II
human histocompatibility leukocyte antigen (HLA) molecules
DQ2 or DQ8 in genetically predisposed individuals, whereas the
latter is determined by the ingestion, digestion, and subsequent
deamidation of certain gluten peptides by tissue transglutaminase
(tTG) [11]. In the small intestine, the deamidated gluten peptides
can bind directly to the HLA-DQ2 or DQ8 receptors on antigen
presenting cells (APCs), and are then presented to gluten-sensitive
T-cells leading to the release of cytokines, which eventually causes
inflammation reactions resulting in damaged intestinal villi [12]. A
delay in diagnosis may cause serious health complications, and
even certain types of cancer in prolonged exposures to gluten.
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Celiac adults present an increased relative risk of suffering non-
Hodgkins lymphoma [13,14], and also other types of gastrointes-
tinal cancer. In addition, CD patients show a 31- to 69-fold
increased risk of dying from lymphoma [15,16], and 18%
prevalence of lymphoma as cause of death [17]. The only effective
treatment available for CD, as well as for other gluten pathologies,
is a lifelong strict gluten-free diet (GFD) [18,19]. However, a GFD
is very complex to follow because gluten is a widespread ingredient
in the food industry and consequently dietary transgressions are
relatively frequent among CD patients (32–55%) [20]. At the same
time, a GFD can be detrimental to gut health as it leads to a
reduction in beneficial microbiota and in the ability of faecal
residues to stimulate the host’s immunity [21]. Thus, potential
alternatives to a GFD are being developed to find new therapies to
reduce or eliminate the appearance of symptoms after consump-
tion of gluten-containing foods [22,23], or to develop new cereals
with reduced levels of the immunotoxic epitopes by transgenesis
approaches [24–27]. Some other studies have reported alternatives
to reduce the content of these epitopes in wheat cultivars. These
strategies are based on the natural genetic variability found in the
Triticum ssp. [28–30], or in the use of deletion or nullisomic wheat
lines [31–33]. However, given the high number and complexity of
the gliadins genes, and that they are inherited in blocks, the
possibility of grouping all the low-toxic gliadin genes in a single
variety with good commercial aptitude seems to be a difficult task.
Previously, we used an RNA interference (RNAi)-mediated gene
silencing approach to down-regulate the content of all a-, c- and
v-gliadins [25], the gluten proteins in which reside the majority of
CD epitopes [34,35]. Flour of these wheat lines is expected to have
low toxicity for CD patients as indicated the reduction in the
ability of total gluten proteins to stimulate gluten-specific T-cells
isolated from CD patients [25]. In addition, some of these lines
presented SDS sedimentation volumes comparable to those of the
wild types, indicating a potential good bread-making quality
[25,36]. In the present study, we report that it is possible to
produce bread of highly acceptable quality made with flour of
these lines. The G12 competitive enzyme-linked immunosorbent
assay (ELISA) indicated lower toxicity than normal wheat flour.
Physical properties, microstructure, and organoleptic quality are
also studied in the reduced-gliadin bread. In addition, we also show
that flour from these lines has improved nutritional properties due
to increased lysine content, which is a desirable trait for improving
the human diet, especially in developing countries. This reduced-
gliadin bread could be extremely important not only for all CD,
gluten sensitive and allergic patients to improve their diet, but also
to reduce the incidence of all gluten related pathologies, which as
in the case of CD, its initiation is associated with the level and
duration of exposure to gluten [37,38].
Materials and Methods
No permits were required for the described study, which
complied with all relevant regulations.
Plant Material
Four transgenic reduced-gliadin lines of Triticum aestivum cv.
Bobwhite 208 (‘BW208’) and three transgenic reduced-gliadin lines
of T. aestivum cv. Bobwhite 2003 (‘BW2003’), and their respective
wild-type lines were assayed using a randomized complete block
design with two replicates. Both wild types are spring wheat
cultivars obtained by the CIMMYT from the cross CM 33203
with the pedigree Aurora//Kalyan/Bluebird/3/Woodpecker.
Cultivar BW2003 has been selected for its high transformation
efficiency, and carries the T1BL.1RS translocation from rye. On
the other hand, BW208 derives from the SH 98 26 ‘Bobwhite’ line
described as highly transformable by Pellegrineschi et al. [39], and
does not contain the rye translocation. In the present study BW208
and BW2003 showed a total protein content of ,11.6% and
,10.5% of dry weight, respectively. The total gluten protein
content (gliadins plus glutenins) was about 8.7% and 7.9% of dry
weight, respectively for BW208 and BW2003.
All the transgenic reduced-gliadin lines were reported previously in
[25], and contained the inverted repeat (IR) fragment v/a (vectors
pGhp-v/a and/or pDhp-v/a) designed to down regulate all the
groups of gliadins by RNAi. Transgenic lines were self-pollinated
for 4–5 generations, and they showed normal phenotypes in
comparison to their corresponding wild types.
Grain Milling
White flour was obtained from each of the two independent
repetitions of the reduced-gliadin and wild-type lines. Grains were
hydrated to 16.5% humidity by addition of distilled water in two
steps (24 h and 20 h before milling) with continuous shaking.
Hydrated seeds (1 kg) of each line were milled separately in two
steps in a CD1 Chopin (Chopin Technologies, Villeneuve-la-
Garenne Cedex, France) standardized test mill. In the first step
white flour and wholemeal flour were obtained. The wholemeal
flour was reloaded in a second step of milling, and the resultant
white flour was blended with that obtained previously, resulting in
a total yield of about 60%. Flour was stored at room temperature
(RT) for a week. Commercial rice flour supplied by Harinera
Derivats del Blat de Moro, S.L. (Parets del Valle´s, Spain) was used
to make the gluten-free control bread.
Bread Baking
Dough was prepared on a flour weight basis: for 300 g flour,
180 ml water (225 ml water for the rice flour), 3.6 g baker’s yeast
(Saf-Instant, Lesaffre, France) and 4.8 g table salt were added.
Ingredients were mixed in a Farinograph (Brabender GmbH &
Co. KG, Germany) for 4 min, and rested for 10 min with a plastic
film cover to avoid drying. Dough was divided manually (50 g) and
dough pieces were rolled mechanically in a ball homogenizer
(Brabender GmbH & Co. KG, Germany). Dough pieces were
placed on aluminum trays and fermented for 45 min at 30uC.
Dough pieces were baked in an electrical convection oven
(Eurofours, Gommegnies, France). The baking process was
performed at fixed oven temperature of 180uC for 16 min with
2 initial steam injections of 10 sec each. After baking, bread loaves
were rested for 30 min at RT to cool down.
Bread Characterization
Bread weight and volume were determined in three loaves from
each sample. Bread volume was determined by the rapeseed
displacement method [40]. Moisture content of the loaves was
determined following the ICC Method No. 110/1 [41], with a
pre-conditioning step of the bread samples. Three loaves from
each sample and their medial slices were scanned (HP Scanjet
4400C, Hewlett–Packard, USA), and height and width were
determined to subsequently calculate the width/height ratio. Crust
and crumb color was determined by a Chroma Meter CR-400
colorimeter (Konica Minolta Sensing Inc., Japan), and expressed
in a CIE-L* a* b* color scale (CIE-Lab). The CIE-Lab color space
is composed by three perpendicular axis: L*, a* and b*. These
three coordinates indicate the lightness of the color (L*; where
L=100 indicates white color and L=0 black color), and its
position between green and red (a*; where negative values indicate
green and positive values indicate red), and between blue and
yellow (b*; where negative values indicate blue and positive values
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indicate yellow). Two independent measurements were made to
each of the three loaves to determine crust and crumb color.
Descriptive Sensory Analysis
A panel of 11 trained assessors was selected to evaluate the
bread samples (n = 20; 10 samples with two repetitions) corre-
sponding to the reduced-gliadin and wild-type wheat flours, and the
rice flour. The range of experience of the test panelists of
participating in descriptive analysis and scale rating of a wide
range of bread products varied from 3 to 20 years. All the
individuals composing the panel gave their informed consent. The
panel evaluated appearance, aroma, flavor, and overall acceptance
of each sample in a blind tasting. For evaluation, a set of six
samples was presented in slices (1 cm thick) on plastic dishes coded
and served in a randomized order. In addition, assessors were
provided with mineral water in order to cleanse their palate
between tastings. Each assessor received a list of sensorial
attributes and their definitions to guide them during the sample
evaluation.
Amino Acids Profile Characterization
Wholemeal flour was used for the characterization of amino
acids profile of reduced-gliadin and wild-type lines. Flour samples
were hydrolyzed using 6 N chloric acid and phenol, and then
derivatized and analyzed. For the derivatization we used the AccQ
Fluor reagent Kit (Waters). First, 20 ml of the hydrolyzed sample
were mixed with 60 ml of buffer solution (0.2 M borate buffer),
and afterwards 20 ml of derivatization reagent (2 mg/ml 6-
aminoquinolyl-N-hydrosysuccinimidyl carbamate, AQC) was add-
ed according to the manufacturer’s instructions. After 10 min at
50uC, the solution was directly injected into the high-performance
liquid chromatography tandem mass spectrometry (HPLC-MS/
MS) system (Varian 320-MS). The amino acid separation was
carried out using 2.5 mM ammonium acetate (pH=5.75) as
solvent A, and a solution of 2.5 mM ammonium acetate (pH=6)
and acetonitrile (30:70, ammonium acetate:acetronitrile) as solvent
B. The Pursuit XRs Ultra 2.8 C18 10062.0 mm column (Agilent)
was used as stationary phase, and the flow was 200 ml/min. The
detection was performed by mass spectrometry (MS) with the
electrospray ionization mode (ESI) (positive and negative). The
amount of amino acid is expressed as percentage of the total
sample weight.
Scanning Electron Microscopy (SEM)
Samples (dough and bread) were frozen and dried, and then
fractured manually by using the tip of a razor blade and coated
with gold. A JEOL JSM6300 scanning electron microscope
(JEOL, Tokyo, Japan) was used to observe the samples at 15 kV
at RT. SEM pictures at 1000x and 3000x magnifications were
taken to the newly exposed surface of each sample. Samples from
lines D894 (reduced gliadin content), E82 (reduced gliadin and low
molecular weight (LMW) glutenin content), and the wild type
BW208 were analyzed.
G12 Competitive ELISA
Gluten proteins were extracted according to the manufacturer’s
instructions using Universal Gluten Extraction Solution UGES
(Biomedal SL, Seville, Spain). Maxisorp microtiter plates (Nunc,
Roskilde, Denmark) were coated with Prolamin Working Group
(PWG) gliadin solution and incubated overnight at 4uC. The plates
were washed with PBS-Tween 20 buffer and blocked with
blocking solution (phosphate-buffered saline (PBS)-5% non-fat
dry milk) for 1 h at RT. Different dilutions of each sample as well
as standard solution of PWG gliadin were made in PBS-bovine
serum albumin 3%, to each of which was added horseradish
peroxidase–conjugated G12 mAb solution. The samples were pre-
incubated at RT and added to the wells. After 30 min of
incubation at RT, the plates were washed, and 3,39,5,59-
tetramethylbenzidine (TMB) substrate solution (Sigma, St. Louis,
Missouri, USA) was added. After 30 min of incubation at RT in
the dark, the reaction was stopped with 1 M sulfuric acid, and the
absorbance at 450 nm was measured (microplate reader
UVM340, Asys Hitech GmbH, Eugendorf, Austria). Results were
expressed in parts per million (ppm) in dry matter for the flour,
and in a 35% humidity basis for the bread loaves. In order to
estimate the total gluten content the results obtained were
multiplied by two. Data were obtained from three independent
experiments with samples run in triplicate.
Statistical Analysis
Data were analyzed with the statistical software R version 2.12.1
[42] using the Graphical User Interface (GUI) R Commander.
Major assumptions of analysis of variance (ANOVA) were
confirmed by the Shapiro-Wilk’s test for normal distribution
(function ‘shapiro.test’, package stats), by the Levene’s test for
homocedasticity (function ‘leveneTest’, package car) and the
Ramsey’s regression equation specification error test (RESET)
for linearity (‘resettest’; package lmtest), and variables were
transformed if required. The statistical analysis between the
different lines was carried out by using the analysis of variance
(ANOVA) model ‘Variable , Line+Block’ (function ‘aov’,
package agricolae), followed by Tukey’s Honestly Significant
Difference (HSD) post hoc all-pairwise comparison test (function
‘HSD.test’, package agricolae). In all the statistical analyses P
values lower than 0.05 were considered significant.
The differences of the amino acids contents between the control
and the low-gluten lines were assessed using the ANOVA model
‘Variable , Block+Line’ with the function ‘lm’ (package stats).
Mean comparisons were carried out by Dunnett’s post hoc
multiple-comparison test (function ‘glht’, package multcomp). The
box-and-whisker plot was plotted with the function ‘boxplot’
(package graphics).
Results and Discussion
Physical Characterization of reduced-gliadin Bread
The reduced-gliadin breads have been characterized and
compared with those from wild-type wheat lines and from rice,
as a control of market-typical gluten-free bread. All bread loaves
were made by using the same formulation, and following the
same mixing and baking methods. The overall visual appearance
was very similar in all the wheat-bread loaves of both wild types
and reduced-gliadin lines (Figure 1A and Figure S1A). The bread
slices were cut mechanically, with both the reduced-gliadin lines
and the wild types presenting similar visual appearance and
porous structure, whereas the rice-bread showed a lighter and
less porous surface than the wheat counterparts (Figure 1A and
Figure S2A). Crust color was very similar in all the samples,
whereas crumb showed greater differences between reduced-gliadin
and wild type lines, and the rice control. The parameter a* (red-
green range) was the most variable color parameter (Figures S1B
and S2B). Although the shape (ratio width/height) and the
weight were comparable in all the wheat loaves independent of
the flour source, the volume (ml) and bread specific volume (ml/
g) were reduced between 20–30% in the reduced-gliadin lines in
comparison with the wild types (Figure 1B). This reduction could
be explained by a reduced capacity of expansion of the dough
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PLOS ONE | www.plosone.org 3 March 2014 | Volume 9 | Issue 3 | e90898
during fermentation. Gliadins are known to contribute to the
extensibility of the dough [43], and consequently, in the reduced-
gliadin lines with all the gliadins down-regulated, the three-
dimensional network formed by gluten proteins appears to have
a reduced extension capacity. Nonetheless, it is sufficient to allow
a significant expansion of the dough during fermentation and
baking process, producing bread loaves of similar crust and
crumb appearance to those made from wild types (Figures S1A
and S2A). As reported by Piston et al. [36] lines D793, E82,
D874, and E93 also presented down-regulation of the LMW
fraction; however, none of the physical parameters studied in the
present paper were significantly affected by this reduction.
Current gluten-free breads available in the market are typically
made with rice or maize flour, and although they represent
economical ingredients, in general the loaf quality, shelf-life and
organoleptic properties are substantially reduced compared to the
wheat-flour counterparts [44]. Furthermore, the substitution of
food with gluten-free alternatives may result in inadequate
intakes of important nutrients since the nutritional properties
(protein, fiber, and essential micronutrients) of gluten-free breads
are frequently reduced [45], producing nutritional deficiencies in
patients suffering gluten-related pathologies [46,47].
Organoleptic Properties of the reduced-gliadin Wheat
Bread are Comparable to that of Normal Bread
A descriptive sensory analysis was carried out by a panel of 11
trained assessors, and the scores were expressed in a 1 to 9 hedonic
scale (Figure 2A). The rice control presented significantly lower
scores than the reduced-gliadin and wild-type wheat lines for all the
parameters, indicating a higher quality of wheat breads. In
addition, most of the reduced-gliadin lines showed statistically
comparable levels of quality with their wild-type counterparts.
Although the overall acceptance was reduced, with an average
score of 7.4 for the wild types and 6.6 for the reduced-gliadin lines, no
significant differences were found between most reduced-gliadin lines
and wild types. By contrast, the overall acceptance of the rice was
significantly lower, presenting a score of 2.4. This indicates, i) there
are no differences in terms of quality between these reduced-gliadin
breads and normal wheat flour breads, and ii) potential consumers
would prefer the reduced-gliadin bread rather than the rice bread. In
addition, a further advantage of the reduced-gliadin bread is that it
can be made using standard, simple recipes, in contrast to the
complex recipes currently used for the manufacture of the rice or
maize gluten-free products, which are necessary to give these
products an acceptable baking and organoleptic quality [48–50].
No differences were found for the organoleptic parameters
between the reduced-gliadin lines with and without reduction of the
Figure 1. Reduced-gliadin bread: physical properties. (A) Loaves and slices of wild-type BW208, reduced-gliadin line D793, and rice. (B) Physical
properties of bread loaves obtained from wild-type lines, reduced-gliadin lines, and rice. Lines with the same letter indicate that no significant
differences exist among them as determined by the Tukey HSD post hoc all-pairwise comparison test (P,0.05).
doi:10.1371/journal.pone.0090898.g001
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LMW fraction. This indicates that, although LMW glutenins play
an important role in the bread-making quality, the down-
regulation of the LMW glutenins in the lines described here does
not affect the overall acceptance of the bread.
The reduced-gliadin Wheat Bread has Increased Lysine
Content
Flour samples from reduced-gliadin wheat and wild types were
compared in terms of amino acid composition (Table S1).
Interestingly, the content of lysine was significantly increased in
all the reduced-gliadin lines (Figure 2B), with increments that ranged
between 24–67% respect to the wild types. In wheat, gliadins are
known to contain lower amounts of lysine (around 50% less) than
glutenins [51]. Consequently, the lysine increase observed in the
reduced-gliadin lines may be an indirect consequence of the down-
regulation of the lysine-poor gliadins and the compensatory
increase in other more lysine-rich grain proteins, like the high
molecular weight (HMW) glutenins or albumins and globulins,
that we have observed in most of these lines [52]. Cereal proteins
generally exhibit poor nutritional quality because of a lack of
balance in amino acid composition and a low content of lysine.
Lysine is considered the most important essential amino acid, and
due to it is not synthesized in animals it must be acquired through
diet. There is great interest in increasing the content of lysine in
cereal crops since it has both an economical and humanitarian
importance, especially in developing countries where the diet is
mainly composed by a single cereal [53,54]. Mutant high-Lys lines
have been obtained in maize opaque-2 mutants [55] and opaque-2-
derived quality protein maize (QPM) lines [56,57]. Genetic
engineering approaches have been also used to increase the lysine
content in maize [58,59] and rice [60]. However, so far there has
not been any study describing high-Lys wheat lines. Previous
studies with opaque-2 mutants and QPM maize lines have
demonstrated the enhancement of the nutritional properties in
Figure 2. Reduced-gliadin bread: organoleptic and nutritional properties. (A) Descriptive sensory analysis. Lines with the same letter indicate
that no significant differences exist among them as determined by the Tukey HSD post hoc all-pairwise comparison test (P,0.05). Sensory scale
ranges from 1–9. Wheat wild types are represented by black bars, reduced-gliadin lines are represented by white bars, and rice is represented by gray
bars. (B) Box-and-whisker plot of lysine content (%) in wild types and reduced-gliadin lines. Dark grey boxes represent the wild-type lines. Significant
differences between reduced-gliadin lines and their respective controls are indicated in pale grey (P,0.1), and white (P,0.05).
doi:10.1371/journal.pone.0090898.g002
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animal (rats, pigs, and chickens) [61–64] and human nutrition
[65,66], with higher utilizable protein values as a consequence of
the lysine increase and a more balanced amino acid composition.
Consequently, the increased content of lysine in the wheat lines
described in this paper potentially confers an increased nutritive
value to the reduced-gliadin breads.
Dough and Bread Crumb Microstructure
Scanning electron microscopy (SEM) was used to study the
microstructure of the dough in reduced-gliadin and wild-type wheat
lines (Figure 3). The micrographs from the wild-type dough
(Figure 3A) showed a distinct gluten film surrounding the small
and large starch granules. Similar microstructures have been
previously observed in wheat doughs [67]. However, in the reduced-
gliadin lines (Figures 3B and 3C) most of the starch granules
appeared naked, especially in the line E82 (Figure 3B). It seems
Figure 3. Dough microstructure in reduced-gliadin and wild-type wheat lines. SEM was carried out at 1000x and 3000x magnifications in
wild type BW208 (A), and reduced-gliadin lines E82 (B), and D894 (C). Arrows indicate starch granules covered by gluten in panel (A), and naked starch
granules in panels (B) and (C).
doi:10.1371/journal.pone.0090898.g003
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that in the reduced-gliadin lines the gluten film is unable to surround
all of the starch granules. A possible explanation for this is that the
lack of gliadins can be affecting the formation of the gluten
structure. It has been previously reported that gliadins may be
involved in the development of the structure of the gluten film
networks through covalent and non-covalent bonding with other
gluten proteins [68]. In addition, some gliadins may be also form
inter-molecular disulfide bonds in the gluten [69], stabilizing the
gluten film during dough formation. Consequently, the inability of
the gluten network to surround the starch granules in the reduced-
gliadin lines can be explained by either the reduction of gliadins,
and/or the increase in the ratio glutenins:gliadins. The micro-
structure of the bread crumb was also analyzed in the reduced-gliadin
and the wild-type wheat lines by SEM (Figure S3). In all cases the
micrographs showed complex network structures with numerous
cavities independently of the line. This network structure
corresponds to gluten threads intimately linked to smooth jelly
areas resulting from starch gelling, as described previously in [67].
In general the wild types displayed bigger pores than the reduced-
gliadin lines, as expected given the higher volume of the wild-type
breads. In Figure S3 it can be observed that the reduced-gliadin line
E82 had a similar microstructure to the wild type, with bigger
pores than the line D894. In addition, in the line D894 elongated
protein strands were more frequently observed.
Predicted Tolerable Daily Intake of reduced-gliadin Bread
by Celiac Patients
Finally, the gluten content expressed in parts per million (ppm)
of flour and bread samples was determined by a competitive
ELISA based on the G12 monoclonal antibody (mAb). The G12
mAb specifically recognizes the hexapeptide QPQLPY present in
the 33-mer peptide of a2-gliadin, binding also to related peptide
variants found in other immunotoxic gluten proteins [70]. The 33-
mer peptide has been identified as one of the digestion-resistant
gluten peptides and the main immunodominant toxic peptide in
celiac patients [71]. The sensitivity and epitope preferences of G12
antibody was found to be useful for detecting gluten-relevant
peptides to infer the potential toxicity of food for patients with CD
[72]. The reactivity of G12 mAb with cereal storage proteins of
different varieties of cereals was correlated with the immunotox-
icity of the dietary grains [73]. We observed that the wild type
BW2003 had a higher content of gluten than its counterpart
BW208 in both flour and bread samples. In addition, all the
reduced-gliadin lines showed a large reduction of the immunotoxicity
in comparison with their respective wild types, with the BW208
reduced-gliadin lines displaying a lower content of gluten than their
BW2003 counterparts (Table 1). The amount of gluten was
strongly decreased in the bread loaves compared to the flour
samples, especially in the reduced-gliadin lines. The lines with the
strongest depletion of gluten in loaves were line D793 (, 97% of
reduction) and line E82 (, 96% of reduction) (Table 1).
These results were compared with the predicted tolerable daily
intake of gluten described by Catassi et al. [74]. In that study, a
daily intake of 50 mg gluten was established as the maximum dose
in order to avoid damage in the small intestine of celiac patients
during a prolonged exposure of 90 days. This means that for the
wild types the maximum tolerated amount of bread per day would
be, in the best of the scenarios, less than 1.9 g. However, for the
line E82 a celiac individual could ingest up to 43.6 g per day of
bread, and for the line D793 the tolerated amount would be of up
to 66.9 g, as determined by the G12 test. In addition, we have
previously reported [25] that the immunotoxicity of the remaining
gluten in these reduced-gliadin wheat lines was up to 100 times lower
than the gluten of the wild type wheat, as determined by T-cell
assays. Consequently, the above estimations of the tolerated daily
intake might be even higher, and still be safe for most of the CD
patients. However, in order to determine whether or not the
product can be consumed by the general celiac and gluten-
intolerant population, as well as the actual tolerated amount that
can be safely ingested, additional studies including feeding trials
with gluten-sensitive/intolerant patients carrying various combi-
nations of the susceptibility genes are still needed.
Conclusions
In the present work, the development of wheat bread suitable
for celiac patients and other gluten-related pathologies is
described. Wheat lines with very low content of the specific gluten
proteins (near gliadin-free) that are the causal agents for
pathologies such as celiac disease were obtained by RNAi. This
reduced-gliadin bread has a higher lysine content and similar bread-
making quality to normal bread, and therefore could enormously
contribute to improve the diet of these patients. Results reported
here represent a great advance in the development of food safe for
Table 1. Gluten content in flour and bread loaves, and estimated maximum tolerable daily intake of bread from wild types and
reduced-gliadin lines.
White flour Bread
Line Total gluten ppm (Mean 6 SE) Depletion (%) Total gluten ppm (Mean 6 SE) Depletion (%) Tolerable daily intake (g)*
BW208 wt 11504261000 266166387 1.9
D793 130736822 88.6 748666 97.2 66.9
D894 268606328 76.7 534962061 79.9 9.3
E82 98316100 91.5 1145.66299 95.7 43.6
E33 2744663572 76.1 2933.16691 89.0 17.0
BW2003 wt 229735623413 12066268971 0.4
D874 3409566674 85.2 1112661710 90.8 4.5
E93 4749561412 79.3 1200261348 90.1 4.2
E140 135786626500 40.9 6262163278 48.1 0.8
Gluten content was calculated by G12 competitive ELISA, and is expressed in parts per million (ppm).
*Maximum tolerable daily intake is based in the results reported by Catassi et al. [74].
doi:10.1371/journal.pone.0090898.t001
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people around the world suffering gluten-related pathologies, with
excellent organoleptic properties and greater nutritional quality.
However, transgenic wheat is highly regulated and, currently, not
commercially grown and this can limit or delay the proposed
strategy. The results presented here indicate that flour and bread
with reduced levels of these gliadins would be safer for gluten
intolerant consumers, although the value of this material still
depends on whether or not it can become commercially available,
or if these results can be translated into something that is
commercially available.
Supporting Information
Figure S1 Loaf samples. (A) Loaves of wild types BW208 and
BW2003, reduced-gliadin lines, and rice; and (B) color graph
indicating the color parameters of wild types, average transgenics
(BW208 and BW2003), and rice. The a*, b* and L* values were
obtained with a Chroma Meter CR-400 colorimeter, and are
represented as fraction of the value respect to the wild-type line
BW208.
(TIFF)
Figure S2 Bread slices. (A) Slices of wild types BW208 and
BW2003, reduced-gliadin lines, and rice; and (B) color graph
indicating the color parameters of wild types, average transgenics
(BW208 and BW2003), and rice. The a*, b* and L* values are
represented as described in Figure S1.
(TIF)
Figure S3 Crumb microstructure of bread samples.
SEM pictures showing the microstructure of the bread crumb in
wild-type BW208 (A), and reduced-gliadin lines D894 (B) and E82
(C). SEM pictures were obtained at 1000x and 3000x magnifica-
tions. Scale bars are shown in each picture.
(TIF)
Table S1 Amino acid content (%) of fresh flour samples of wild
types and low-gliadin lines.
(DOCX)
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